Home ›
Trademark Categories ›
Pharmaceuticals ›
2009 ›
BE ›
BELIXOS
Trademark search for:
BELIXOS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2009-05-27 — Application filed
2009-08-06 — Sn assigned for sect 66a appl from ib
2009-08-07 — Application filed
2009-08-11 — Application filed
2009-08-27 — Assigned to examiner
2009-09-03 — Final disposition recorded
2009-09-04 — Office action issued
2009-09-04 — Office action issued
2009-09-04 — Office action issued
2009-09-18 — Correction transaction received from ib
2009-09-23 — Correction from ib entered - no review required
2009-09-29 — Office action issued
2009-11-06 — Limitation of goods received from ib
2009-11-24 — Teas change of correspondence received
2009-11-24 — Office action issued
2009-12-11 — Approved for pub - principal register
2009-12-11 — Teas/email correspondence entered
2009-12-11 — Applicant/correspondence changes (non-responsive) entered
2009-12-11 — Assigned to lie
2009-12-11 — Correspondence received in law office
2009-12-14 — Law office publication review completed
2010-01-19 — Published for opposition
2010-01-19 — Official gazette publication confirmation e-mailed
2010-04-06 — Registered-principal register
2010-07-07 — Final disposition recorded
2010-07-28 — Limitation from the ib examined, no action is needed
2010-07-28 — Final disposition recorded
2010-07-28 — Final disposition recorded
2012-09-28 — Limitation of goods received from ib
2012-10-04 — Correction under section 7 - processed
2012-10-04 — Limitation from the ib examined and entered
2012-10-04 — Assigned to paralegal
2013-02-07 — Final disposition recorded
2013-06-04 — Partial invalidation of reg ext protection created
2014-04-30 — Invalidation reviewed - no action required by office
2014-07-04 — Limitation of goods received from ib
2014-07-23 — Limitation from the ib examined and entered
2014-07-24 — Correction under section 7 - processed
2014-07-24 — Assigned to paralegal
2015-03-24 — Partial invalidation of reg ext protection created
2015-07-15 — Invalidation reviewed - no action required by office
2015-08-27 — Teas change of correspondence received
2015-08-28 — Teas change of correspondence received
2015-11-28 — Teas section 71 received
2016-01-08 — Case assigned to post registration paralegal
2016-01-08 — Registered-sec.71 accepted
2016-01-08 — Notice of acceptance of sec. 71 - e-mailed
2016-09-08 — Partial invalidation of reg ext protection created
2016-09-08 — Partial invalidation of reg ext protection sent to ib
2016-09-08 — Invalidation processed
2017-05-12 — Teas change of correspondence received
2017-05-12 — Partial invalidation processed by the ib
2019-04-06 — Courtesy reminder - sec. 71 (10-yr) e-mailed
2019-06-13 — International registration renewed
2021-02-26 — Cancelled section 71
2021-02-26 — Final status recorded
2021-10-26 — Total invalidation of reg ext protection created
2021-12-18 — Invalidation processed
2021-12-19 — Total invalidation of reg ext protection sent to ib
2022-01-15 — Total invalidation processed by the ib
Owner Information
Biofrontera Pharma GmbH
51377 Leverkusen DE
Biofrontera Pharma GmbH
DE
Biofrontera Pharma GmbH
DE
Correspondent
JENNIFER FRASER Dykema Gossett PLLC 1301 K Street, NW Suite 1100 West Washington, DC 20005
Filing Details
Filing Date:
2009-05-27
Status Date:
2021-02-26
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.